MiR-27 as a Prognostic Marker for Breast Cancer Progression and Patient Survival
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-27 as a Prognostic Marker for Breast Cancer Progression and Patient Survival
Authors
Keywords
Breast cancer, Metastasis, Cell staining, Multivariate analysis, Histology, Immunohistochemistry techniques, MicroRNAs, Metastatic tumors
Journal
PLoS One
Volume 7, Issue 12, Pages e51702
Publisher
Public Library of Science (PLoS)
Online
2012-12-12
DOI
10.1371/journal.pone.0051702
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation
- (2012) Nivedita Banerjee et al. BREAST CANCER RESEARCH AND TREATMENT
- miRNA Signatures Associate with Pathogenesis and Progression of Osteosarcoma
- (2012) K. B. Jones et al. CANCER RESEARCH
- Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cells
- (2012) Gayathri Chadalapaka et al. CARCINOGENESIS
- MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A
- (2011) C. Urbich et al. BLOOD
- Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors
- (2011) Sudhakar Chintharlapalli et al. BMC CANCER
- High level of miR-21, miR-10b, and miR-31 expression in bilateral vs. unilateral breast carcinomas
- (2011) Aglaya G. Iyevleva et al. BREAST CANCER RESEARCH AND TREATMENT
- MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression
- (2011) Mikael Lerner et al. CELL CYCLE
- A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL
- (2011) Bo-Wei Han et al. HUMAN MOLECULAR GENETICS
- Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells
- (2011) Xiaohong Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition
- (2011) Ziping Zhang et al. Cancer Genetics
- miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2
- (2010) Yihui Ma et al. CANCER LETTERS
- MicroRNA-27a Indirectly Regulates Estrogen Receptor α Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells
- (2010) Xiangrong Li et al. ENDOCRINOLOGY
- A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis
- (2010) Rui Liu et al. EUROPEAN JOURNAL OF CANCER
- MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells
- (2010) Zhimin Li et al. GYNECOLOGIC ONCOLOGY
- GT-094, a NO-NSAID, Inhibits Colon Cancer Cell Growth by Activation of a Reactive Oxygen Species-MicroRNA-27a: ZBTB10-Specificity Protein Pathway
- (2010) S. S. Pathi et al. MOLECULAR CANCER RESEARCH
- Methyl 2-Cyano-3,12-dioxooleana-1,9-dien-28-oate Decreases Specificity Protein Transcription Factors and Inhibits Pancreatic Tumor Growth: Role of MicroRNA-27a
- (2010) I. Jutooru et al. MOLECULAR PHARMACOLOGY
- Role of specific microRNAs for endothelial function and angiogenesis
- (2009) Fusheng Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Down-Regulation of miR-27a Might Reverse Multidrug Resistance of Esophageal Squamous Cell Carcinoma
- (2009) Hongwei Zhang et al. DIGESTIVE DISEASES AND SCIENCES
- Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18β-olean-1,12-dien-30-oate in colon cancer cells
- (2009) Sudhakar Chintharlapalli et al. INTERNATIONAL JOURNAL OF CANCER
- Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells
- (2009) Irene K. Guttilla et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA Signature Predicts Survival and Relapse in Lung Cancer
- (2008) Sung-Liang Yu et al. CANCER CELL
- MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin
- (2008) Tao Liu et al. CANCER LETTERS
- MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
- (2008) Aaron J. Schetter et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?
- (2008) Witold Filipowicz et al. NATURE REVIEWS GENETICS
- Aberrant Expression of Oncogenic and Tumor-Suppressive MicroRNAs in Cervical Cancer Is Required for Cancer Cell Growth
- (2008) Xiaohong Wang et al. PLoS One
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started